Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma

Hematological Oncology

Volumn 24, Issue 4, 2006, Pages 234-237

  Biehn, Suzanne E ^a,b   Kirk, David ^a   Rivera, M Patricia ^a   Martinez, Antonio E ^a   Khandani, Amir H ^a   Orlowski, Robert Z ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Brochiolitis obliterans organizing pneumonia; Lymphoma; Rituximab

Indexed keywords

LEVOFLOXACIN; PREDNISONE; RITUXIMAB;

ADULT; ANAMNESIS; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG INFECTION; MALE; NONHODGKIN LYMPHOMA; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; RADIODIAGNOSIS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION;

EID: 33845927593     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.799     Document Type: Article

References (22)

1. Maloney DG, Grillo-Lopez AJ, Bodkin DJ, et al. IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 3266-3274.
2. Maloney DG, Grillo-Lopez AJ, White CA, et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997; 90: 2188-2195.
3. McLaughlin P, White CA, Grillo-Lopez AJ, Maloney DG. Clinical status and optimal use of rituximab for B-cell lymphomas. Oncology (Williston Park) 1998; 12: 1763-1769; discussion 1769-1770, 1775-1777.
4. McLaughlin P, Grillo-Lopez AJ, Link BK, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998; 16: 2825-2833.
5. Piro LD, White CA, Grillo-Lopez AJ, et al. Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol 1999; 10: 655-661.
6. Davis TA, White CA, Grillo-Lopez AJ, et al. Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab. J Clin Oncol 1999; 17: 1851-1857.
7. Davis TA, Grillo-Lopez AJ, White CA, et al. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. J Clin Oncol 2000; 18: 3135-3143.
8. Genentech. Rituxan and pulmonary events. 2003.
9. Byrd JC, Peterson BL, Morrison VA, et al. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood 2003; 101: 6-14.
10. Macartney C, Burke E, Elborn S, et al. Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim. Leuk Lymphoma 2005; 46: 1523-1526.
11. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001; 161: 158-164.
12. Epler GR. Drug-induced bronchiolitis obliterans organizing pneumonia. Clin Chest Med 2004; 25: 89-94.
13. Jacobs C, Slade M, Lavery B. Doxorubicin and BOOP. A possible near fatal association. Clin Oncol (R Coll Radiol) 2002; 14: 262.
14. Patel M, Ezzat W, Pauw KL, Lowsky R. Bronchiolitis obliterans organizing pneumonia in a patient with chronic myelogenous leukemia developing after initiation of interferon and cytosine arabinoside. Eur J Haematol 2001; 67: 318-321.
15. Kalambokis G, Stefanou D, Arkoumani E, Kitsanou M, Bourantas K, Tsianos EV. Fulminant bronchiolitis obliterans organizing pneumonia following 2 d of treatment with hydroxyurea, interferon-alpha and oral cytarabine ocfosfate for chronic myelogenous leukemia. Eur J Haematol 2004; 73: 67-70.
16. Kalambokis G, Stefanou D, Arkoumani E, Tsianos E. Bronchiolitis obliterans organizing pneumonia following chlorambucil treatment for chronic lymphocytic leukemia. Eur J Haematol 2004; 73: 139-142.
17. Tenholder MF, Becker GL, Cervoni MI. The myelodysplastic syndrome and bronchiolitis obliterans. Ann Intern Med 1990; 112: 714-715.
18. Stemmelin GR, Bernaciak J, Casas JG. Bronchiolitis with leukemia. Ann Intern Med 1991; 114: 912-913.
19. Matsuo K, Tada S, Kataoka M, et al. Bronchiolitis obliterans organizing pneumonia (BOOP) in a case of smouldering adult T-cell leukaemia. Respirology 2000; 5: 81-85.
20. Akira M, Yamamoto S, Sakatani M. Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR 1998; 170: 291-295.
21. Bouchardy LM, Kuhlman JE, Ball WC et al. CT findings in bronchiolitis obliterans organizing pneumonia (BOOP) with radiographic, clinical, and histologic correlation. J Comput Assist Tomogr 1993; 17: 352-357.
22. Shin L, Katz DS, Yung E. Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia. Clin Nucl Med 2004; 29: 654-656.